NASDAQ Biotechnology NBI 指数
3993.52 USD
{{ price }}
-1.904866%
{{change_pct}}%
NASDAQ Biotechnology 价格走势图
过去24小时内的前5名涨幅最大者
| HUMA | Humacyte | +31.06% | |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | +28.22% | |
| CTMX | CytomX Therapeutics | +17.37% | |
| OMER | Omeros | +16.73% | |
| ITOS | iTeos Therapeutics | +13.44% |
过去24小时内的前5名跌幅最大者
| AFMD | Affimed | -80.66% | |
|---|---|---|---|
| SGMO | Sangamo Therapeutics | -38.4% | |
| NSTG | NanoString | -37.43% | |
| RAIN | Rain Enhancement Technologies Holdco | -24.83% | |
| HALO | Halozyme Therapeutics | -24.56% |
NASDAQ Biotechnology NBI 财务与交易概览
| NASDAQ Biotechnology指数价格 | 3993.52 USD |
| 昨日收盘价 | 3985.14 USD |
| 开盘价 | 3992.23 USD |
| 买入价 | 0 USD x 0 |
| 卖出价 | 0 USD x 0 |
| 当日价格范围 | 3904.9 - 4026.01 USD |
| 52 周价格范围 | 3568.35 - 4954.81 USD |
| 成交量 | 0 USD |
| 平均成交量 | 0 USD |
交易信息
NASDAQ Biotechnology 指数价格历史
| 52 周最高 | 4954.81 USD |
| 52 周最低 | 3568.35 USD |
| 50 天移动平均线 | 4216.31 USD |
| 200 天移动平均线 | 4530.7 USD |
NBI Index Statistics
| 平均成交量（3 个月） | 0 USD |
| 平均每日成交量（10 天） | 0 USD |
NASDAQ Biotechnology指数问答
什么是当前的NBI指数价格？
NASDAQ Biotechnology NBI指数今天的价格是3993.52 USD。
如何购买NASDAQ Biotechnology指数？
您可以在Nasdaq GIDS交易所购买NBI指数。请联系您的财务顾问以选择经纪商。
NASDAQ Biotechnology指数的股票代码是什么？
NASDAQ Biotechnology指数的股票代码是NBI。
NASDAQ Biotechnology指数包含多少个成分？
NASDAQ Biotechnology指数包含389个成分。
NASDAQ Biotechnology指数属于哪个国家？
NASDAQ Biotechnology指数所属国家是United States。
NASDAQ Biotechnology指数属于哪个交易所？
NASDAQ Biotechnology指数所属交易所是Nasdaq GIDS。
NASDAQ Biotechnology 成分
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| AstraZeneca AZN | $67.72 — |
-1.78
|
$211.58B — | $4.72M — | $67.39 — | $68.44 — | $211.58B — | 27.19 | $2.49 — |
| Amgen AMGN | $270.45 — |
-1.57
|
$145.42B — | $2.65M — | $268.53 — | $273.92 — | $145.42B — | 24.63 | $10.98 — |
| Gilead Sciences GILD | $101.43 — |
-2.3
|
$126.28B — | $8.29M — | $100.73 — | $102.83 — | $126.28B — | 21.30 | $4.76 — |
| Sanofi SNY | $49.96 — |
-2.15
|
$125.13B — | $2.97M — | $49.86 — | $50.71 — | $125.13B — | 17.84 | $2.8 — |
| Vertex Pharmaceuticals Incorporated VRTX | $432 — |
-1.68
|
$110.94B — | $2.64M — | $429.54 — | $442.07 — | $110.94B — | 0 | -$3.8 — |
| Regeneron Pharmaceuticals REGN | $574.16 — |
-0.26
|
$61.99B — | $1.07M — | $558.45 — | $575.01 — | $61.99B — | 14.59 | $39.33 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $266.86 — |
-1.23
|
$34.8B — | $715.16K — | $261.45 — | $267.85 — | $34.8B — | 0 | -$2.11 — |
| argenx SE ARGX | $542.47 — |
-3.29
|
$34.19B — | $685.92K — | $538.09 — | $557.37 — | $34.19B — | 33.11 | $16.38 — |
| BioNTech SE BNTX | $94.5 — |
-2.85
|
$22.72B — | $763.9K — | $94.26 — | $97.21 — | $22.72B — | 0 | -$3.58 — |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — |
| Royalty Pharma RPRX | $32.82 — |
-1.59
|
$18.45B — | $4.27M — | $32.55 — | $33.09 — | $18.45B — | 13.39 | $2.45 — |
| Summit Therapeutics SMMT | $24.61 — |
-2.57
|
$18.28B — | $2M — | $24.21 — | $25.5 — | $18.28B — | 0 | -$0.34 — |
| Biogen BIIB | $123.16 — |
-1
|
$18.05B — | $1.67M — | $121.6 — | $124.14 — | $18.05B — | 12.16 | $10.12 — |
| Intra-Cellular Therapies ITCI | $131.87 — |
0
|
$14.05B — | $0 — | $0 — | $0 — | $14.05B — | 0 | $0 — |
| United Therapeutics UTHR | $308.07 — |
-0.88
|
$13.9B — | $560K — | $302.01 — | $310.09 — | $13.9B — | 12.26 | $25.11 — |
| Illumina ILMN | $80.3 — |
-1.56
|
$12.71B — | $2.32M — | $80.17 — | $82.44 — | $12.71B — | 0 | -$6.08 — |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — |
| Genmab A/S GMAB | $19.31 — |
-3.11
|
$12.01B — | $2.18M — | $18.89 — | $19.52 — | $12.01B — | 11.29 | $1.71 — |
| Insmed Incorporated INSM | $65.71 — |
-3.01
|
$11.97B — | $2.13M — | $65.54 — | $68.35 — | $11.97B — | 0 | -$5.93 — |
- {{ link.label }} {{link}}